Author(s): Gopal Muthuboopathi, Arthanari Saravanakumar, Sangeetha Saravanan, Govindaraj Anandharaj, Heera Gurusamy, Mahalingam Loganathan, Prakash Manivasakam, Narayanan Venkateshan3, Balasubramanian Lakshminarayanan, Balasubramaniam Periyanayaki, Dhanush Kumar Kesavan, Shreevarshaa Selvamani, Vaishnavi Kanagarajan, Periyasamy Parthiban
DOI: 10.52711/0974-360X.2026.00536
Views:
0
(pdf),
28
(html)
Access:
Closed Access
Cite: Gopal Muthuboopathi, Arthanari Saravanakumar, Sangeetha Saravanan, Govindaraj Anandharaj, Heera Gurusamy, Mahalingam Loganathan, Prakash Manivasakam, Narayanan Venkateshan3, Balasubramanian Lakshminarayanan, Balasubramaniam Periyanayaki, Dhanush Kumar Kesavan, Shreevarshaa Selvamani, Vaishnavi Kanagarajan, Periyasamy Parthiban. An In silico Anticancer and Antitubercular potential of Aryl/Alkyl Amino Substituted-dene-2-(1,3-diphenylallylidene) hydrazine derivatives against HER2 and MBTB gyrase type IIA topoisomerase inhibitors. Research Journal of Pharmacy and Technology. 2026;19(8):3802-8. doi: 10.52711/0974-360X.2026.00536
Read More